Frontage Laboratories acquires Concord Biosciences

Frontage is a full-service CRO (contract research organization) with locations in the US and China supporting pharmaceutical clients in their drug development efforts since 2001. Service offerings include analytical testing, product development, DMPK, bioanalysis, clinical, and biometrics. Frontage proudly serves generic, innovator and consumer health companies from IND enabling through late stage clinical projects. Frontage successfully assists clients to advance hundreds of molecules through clinical development to commercial launch in global markets.